Medical
Remedy Robotics said it raised $62 million in a new funding round to support work toward FDA approval for neurovascular procedures.
A dated step forward on the record · Company-reported
What the source says
“said it raised $62 million in a new funding round”
What it means
Money is not the same as progress up our ladder. N1 stays at stage 1, Demo only, because nothing on the record shows a paid use or a named customer. The company says it works with more than 100 hospitals, but that is its own claim and names no setting. All ten other robots in Surgical and medical sit at stage 5, so N1 has a long way to go. So far the funding shows intent to seek FDA approval, not clearance.
N1, from Remedy Robotics, is at stage 1 of 5 on our ladder: demo only. Its stage is set by other milestones on its record; this one adds to the history. This line rests on the company's own announcement; no regulator, customer or independent report confirms it in our sources yet.
Human help: People working remotely can steer it or take over.
Written with AI from our record of N1 and checked against it: every figure appears in that record.
